Pricing Log in Create free account

Anavex Life Sciences Corp. (AVXL) vs Outlook Therapeutics, Inc. (OTLK)

Anavex Life Sciences Corp. and Outlook Therapeutics, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Outlook Therapeutics, Inc. are of similar size ($106.9M and $102.9M). Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Outlook Therapeutics, Inc. leads on 7 and Anavex Life Sciences Corp. on 4.

Valuation

Metric AVXL OTLK Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.95 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.67 n/m 0.66
EV/Sales n/m (66.10) 9.02
Earnings yield (13.04%) (200.49%) (32.88%)
Free cash flow yield (27.48%) (96.25%) (23.13%)

Profitability

Metric AVXL OTLK Biotechnology median
Gross margin — 195.62% 68.51%
Operating margin 0.00% 4,781.76% 0.00%
Net margin 0.00% 5,253.40% 0.00%
Free cash flow margin 0.00% 4,826.38% 0.00%
Return on equity (12.80%) 256.92% (51.96%)
Return on assets (11.70%) (251.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL OTLK Biotechnology median
Revenue growth (TTM) — (113.55%) 6.76%
EPS growth (last fiscal year) (3.85%) 55.81% 29.88%
Revenue growth, 5-year CAGR — (22.99%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL OTLK Biotechnology median
Debt to equity 0.00 (1.75) 0.00
Current ratio 15.62 0.81 4.97
Net debt to EBITDA 2.00 (0.33) 1.01

Dividend

Metric AVXL OTLK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVXL OTLK Biotechnology median
Market cap 102.90m 106.90m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack